Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Memorial Sloan-Kettering Cancer Center
Sponsor:
Collaborators:
The City College of New York
Lincoln Medical and Mental Health Center
New York Hospital Queens
Ralph Lauren Center for Cancer Care and Prevention
New York City Health and Hospitals Corporation
Queens Medical Associates
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01134172
First received: May 27, 2010
Last updated: July 3, 2014
Last verified: July 2014
  Purpose

The purpose of this study is to learn more about how being treated for breast cancer affects patients' employment, financial situation, and quality of life on a short-term basis and on a longterm basis. Most studies of employment after breast cancer have focused on Caucasian women.This study will evaluate the impact of breast cancer on the lives of women from different ethnic groups.


Condition Intervention
Breast Cancer
Behavioral: survey web-based or telephone interview

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Breast Cancer and the Workforce: Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life (BCW)

Resource links provided by NLM:


Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • To compare the impact of breast cancer on (a) employment status, (b) financial situation, and (c) QoL. [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To identify barriers to employment and correlates of employment status, financial situation, and QoL. [ Time Frame: 3 years ] [ Designated as safety issue: No ]
  • To develop the methodology to evaluate discrimination in the labor market using a validated instrument and to determine whether or not labor market discrimination is exacerbated by a diagnosis of breast cancer. [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 750
Study Start Date: May 2010
Estimated Study Completion Date: May 2015
Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Breast cancer survivors
Women being treated for stage I-III breast cancer who were employed prior to this diagnosis will be recruited in their physicians' offices.
Behavioral: survey web-based or telephone interview
Patients will be asked to complete a questionnaire at baseline, and then one at follow up, 3-4 months after treatment completion. The patient will be contacted one and two years after the completion of their follow up questionnaire for a brief one-question survey regarding current employment status.
Comparison group
Peer controls will be nominated by participants in the breast cancer survivor group or recruited by community outreach and matched for age, language, and ethnicity.
Behavioral: survey web-based or telephone interview
Patients will be asked to complete a questionnaire at baseline, and then one at follow up, 3-4 months after treatment completion.

  Eligibility

Ages Eligible for Study:   18 Years to 64 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

We will recruit participants from Memorial Sloan-Kettering Cancer Center (MSKCC), four of its community-based outpatient treatment centers, and four urban community hospitals and clinics that serve large populations of ethnic minorities in New York City. The MSKCC outpatient regional sites are located in New Jersey (Basking Ridge) and New York, with two in Long Island (Commack and Rockville Centre) and another in Westchester County (Sleepy Hollow).

Criteria

Inclusion Criteria:

Breast cancer survivors

  • Pathologic diagnosis of stage I-III breast cancer
  • Paid employment (full time or part time) at time of consent or in the three months prior to diagnosis
  • Age 18 to 64 years (inclusive)
  • The ability to give informed consent in Chinese (Mandarin), English, Korean, or Spanish.at MSK, New York Hospital Queens and Queens Medical Associates At Lincoln Medical and Mental Health Center, patients must be able to give consent in English or Spanish.
  • At the time of enrollment, participants must still be undergoing chemotherapy, undergoing radiation therapy, or planning surgery unless surgery is to be the only treatment modality. Those for whom treatment consists of surgery alone may have had their operation no more than 1 month prior to study enrollment. Participants need not have undergone surgical reconstruction prior to enrollment if the plan is to delay this procedure until after primary treatment is completed.

Comparison group

Paid employment (full time or part time) at the time of consent

  • Age 18 to 64 years (inclusive) and within an age range that is 5 years above or below that of the nominating or matched survivor
  • The ability to give informed consent in the same language as the nominating survivor
  • Membership in the same ethnic group as the nominating survivor
  • Not treated for cancer in the past year (other than non-melanoma skin cancer)

Exclusion Criteria:

  • N/A
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01134172

Contacts
Contact: Victoria Blinder, M.D., M.Sc. 646-888-4808
Contact: Francesca Gany, M.D., M.Sc. 646-888-4240

Locations
United States, New Jersey
Memoral Sloan Kettering Cancer Center Recruiting
Basking Ridge, New Jersey, United States
Contact: Victoria Blinder, M.D., M.Sc    646-888-4808      
United States, New York
Lincoln Medical and Mental Health Center Recruiting
Bronx, New York, United States, 10451
Contact: Niyati Bhagwati, MD    718-579-5000      
Principal Investigator: Niyati Bhagwati,, MD         
Woodhull Medical and Mental Health Center Completed
Brooklyn, New York, United States, 11206
Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting
Commack, New York, United States, 11725
Contact: Victoria Blinder, M.D., M.Sc    646-888-4808      
Queens Medical Associates Not yet recruiting
Fresh Meadows, New York, United States, 11366
Contact: Gabriel Jung, MD         
Principal Investigator: Gabriel Jung, MD         
Bellevue Hospital Center Completed
New York, New York, United States
Memorial Sloan Kettering Cancer Center Recruiting
New York, New York, United States, 10065
Contact: Victoria Blinder, M.D., M.Sc    646-888-4808      
Contact: Ethan Basch, M.D., M.Sc    646-422-4426      
Ralph Lauren Center for Cancer Care and Prevention Recruiting
New York, New York, United States
Contact: Joseph R Yoe, MD         
Principal Investigator: Joseph R Yoe, MD         
New York Hospital - Queens Recruiting
Queens, New York, United States, 11355
Contact: Manmeet Malik, D.O.         
Principal Investigator: Manmeet H Malik, D.O.         
Memorial Sloan Kettering at Mercy Medical Center Recruiting
Rockville Centre, New York, United States
Contact: Victoria Blinder, M.D., M.Sc    646-888-4808      
Memoral Sloan Kettering Cancer Center at Phelps Recruiting
Sleepy Hollow, New York, United States, 10591
Contact: Victoria Blinder, M.D., M.Sc    646-888-4808      
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
The City College of New York
Lincoln Medical and Mental Health Center
New York Hospital Queens
Ralph Lauren Center for Cancer Care and Prevention
New York City Health and Hospitals Corporation
Queens Medical Associates
Investigators
Principal Investigator: Victoria Blinder, M.D., M.Sc. Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT01134172     History of Changes
Other Study ID Numbers: 10-071
Study First Received: May 27, 2010
Last Updated: July 3, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
Sociodemographic
Ethnicity
Work-related
Health system
QOL
Questionnaires
10-071

Additional relevant MeSH terms:
Breast Neoplasms
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases

ClinicalTrials.gov processed this record on November 20, 2014